文献速递胃肠动力与功能性疾病

阿米替林与艾司西酞普兰对功能性消化不良患者睡眠和情绪的影响

Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-12-01

该研究为一项多中心双盲试验的事后分析,纳入292例功能性消化不良患者,随机接受阿米替林50mg、艾司西酞普兰10mg或安慰剂治疗12周。结果显示三组心理与睡眠量表评分在12周后无显著差异,但阿米替林组睡眠时长评分优于安慰剂组和艾司西酞普兰组(P=0.019)。作者认为阿米替林改善FD症状的机制可能不涉及心理痛苦的减轻,但可能适度改善睡眠。

要点

  • 阿米替林50mg、艾司西酞普兰10mg或安慰剂治疗12周后,三组心理与睡眠量表评分无显著差异。
  • 阿米替林组睡眠时长评分低于安慰剂组和艾司西酞普兰组(P=0.019),提示睡眠改善。
  • 所有组中症状应答者的焦虑评分降低且部分睡眠成分改善。

核心结论

  • 在功能性消化不良患者中,阿米替林可减轻FD症状,但其机制可能不涉及心理痛苦的减轻,该药可能适度改善睡眠。

研究设计与样本

  • 多中心、双盲随机临床试验的事后分析,纳入292例功能性消化不良患者,随机分为阿米替林50mg组、艾司西酞普兰10mg组或安慰剂组,治疗12周。

主要发现

  • 基线时各组心理和睡眠测量评分相似,治疗12周后各组间评分无显著差异。
  • 基线时所有组整体匹兹堡睡眠质量指数平均分均提示睡眠质量差,12周后仍如此。
  • 阿米替林组睡眠时长评分低于安慰剂组和艾司西酞普兰组(P=0.019)。
  • 在所有组中,应答者焦虑评分降低且部分睡眠成分改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Tricyclic antidepressants are effective in reducing symptoms of functional dyspepsia (FD). We performed a post hoc analysis of data from a previous randomized clinical trial to determine whether the benefits of an antidepressant on gastrointestinal symptoms in patients with FD were mediated by improving sleep or reducing anxiety. We explored the relationships between psychological measures, quality of sleep, and relief of symptoms. METHODS: We analyzed data from a multicenter, double-blind trial that evaluated the efficacy of antidepressants on symptoms of FD, from October 2006 through October 2012. Patients (n = 292) were randomly assigned to groups given 50 mg amitriptyline, 10 mg escitalopram, or placebo for 12 weeks. During the study, participants completed the following validated psychological questionnaires: Symptom Check List 90, Symptom Somatic Checklist, Hospital Anxiety Depression Scale, Profile of Mood States, State Trait Anxiety Inventory, and Pittsburgh Sleep Quality Index at baseline and 12 weeks following treatment. RESULTS: Baseline scores for the psychological and sleep measures were similar among groups; after 12 weeks there were no significant differences in scores among groups. Baseline mean global Pittsburgh Sleep Quality Index scores indicated poor sleep quality in all groups at baseline and after 12 weeks. Overall, antidepressants affected sleep duration scores: patients given amitriptyline had lower (better) scores than patients given placebo or escitalopram (P = .019). In all groups, responders had decreased anxiety and improvements in some sleep components. CONCLUSIONS: In a post hoc analysis of data from a clinical trial that evaluated the effects of antidepressants in patients with FD, amitriptyline was found to reduce symptoms of FD, but its mechanism is unlikely to involve reductions in psychological distress. The drug may modestly improve sleep. Clinicaltrials.gov no: NCT00248651.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Herrick LM, Camilleri M, Schleck CD, et al. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol. 2017. PMID: 29199141. doi:10.1016/j.cgh.2017.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。